Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Recurrent or Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02119468
What this trial is testing

Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell MyelomaRecurrent Plasma Cell Myeloma
City of Hope Medical Center 32
Early research (Phase 1)Study completedNCT01301807
What this trial is testing

Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Non-Secretory Plasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more
M.D. Anderson Cancer Center 63
Early research (Phase 1)Ended earlyNCT00004239
What this trial is testing

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Study completedNCT01145989
What this trial is testing

AT9283 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
NCIC Clinical Trials Group 8
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT01866293
What this trial is testing

Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00401011
What this trial is testing

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaMultiple Myeloma in Relapse
AEterna Zentaris 84
Early research (Phase 1)Study completedNCT00718601
What this trial is testing

Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma

Who this might be right for
Multiple Myeloma
Geron Corporation 40
Early research (Phase 1)Looking for participantsNCT06622005
What this trial is testing

SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Testing effectiveness (Phase 2)Study completedNCT00708292
What this trial is testing

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Novartis Pharmaceuticals 29
Early research (Phase 1)Study completedNCT02948283
What this trial is testing

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Who this might be right for
AnemiaFatigueFever+10 more
City of Hope Medical Center 3
Testing effectiveness (Phase 2)WithdrawnNCT02985333
What this trial is testing

Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapse/Refractory Multiple Myeloma
Sun Yat-sen University
Early research (Phase 1)Study completedNCT02468687
What this trial is testing

NMP in Relapsed / Refractory Myeloma

Who this might be right for
Multiple Myeloma
Peter MacCallum Cancer Centre, Australia 13
Early research (Phase 1)Study completedNCT01129193
What this trial is testing

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more
Amir Mortazavi 44
Testing effectiveness (Phase 2)Study completedNCT02506959
What this trial is testing

Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Plasma Cell LeukemiaPlasmacytomaRecurrent Plasma Cell Myeloma+1 more
M.D. Anderson Cancer Center 83
Not applicableNo Longer AvailableNCT00423826
What this trial is testing

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT00079716
What this trial is testing

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 44
Testing effectiveness (Phase 2)Study completedNCT00060255
What this trial is testing

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerLeukemiaLymphoma+4 more
Roswell Park Cancer Institute 451
Early research (Phase 1)Study completedNCT02116569
What this trial is testing

Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Pharmaceutical K.K. 9
Next Page